See also this year's filing and all EDGAR filings for this company.
PDF Report 0000827871_2016_Eagle_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000827871, Eagle Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 122,257,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,205,000 |
| 3 | remainder_Assets | 143,000 |
| 4 | LiabilitiesCurrent | 34,262,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 15,647,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 20,165,000 |
| 9 | ResearchAndDevelopmentExpense | 27,855,000 |
| 10 | remainder_Expenses | 3,000 |
| 11 | remainder_Revenues | 66,227,000 |
| 12 | remainder_NetIncome | 14,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 124,605,000 |
| 1 | Liabilities | 34,262,000 |
| 2 | Expenses | 63,670,000 |
| 3 | Revenues | 66,227,000 |
| 4 | StockholdersEquity | 90,343,000 |
| 5 | NetIncome | 2,571,000 |
| 6 | ComprehensiveNetIncome | 2,571,000 |
| 7 | BaseVar | 144,389,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.51 |
| 9 | EconomicCapitalRatio | 3.36 |
Edgar->Model Mapping
Feature Distribution
